Rocket Health, an international telemedicine and last mile healthcare company, has raised US$5million Series A funding to help it develop its technology roadmap, and expand into Kenya and Uganda.
The funding round was led by Creadev, an investment company that has been around since its inception, which is owned by the Mulliez family, a French family of entrepreneurs. Creadev was joined by LoftyInc Capital Management and Grenfell Holdings, both early-stage African investors.
Rocket Health, which was founded in 2012, is Uganda’s leading telemedicine provider, providing an end-to-end healthcare experience to over 25,000 patients.
The startup’s approach makes use of technology to provide four integrated services: 24-hour teleconsultations, medication delivery, home sample collection for laboratory diagnostic tests, and physical specialist clinic appointments.
“Through the exponential power of technology, Rocket Health is on a mission to make great primary healthcare accessible, affordable, and convenient to achieve the best outcomes for as many Africans as possible,” said Dr. Davis Musinguzi, Rocket Health’s founder and CEO.
“We’re delighted that Creadev and the Mulliez family’s investment thesis aligns so well with the Rocket Health founding team’s timeless mission.” Together, we will create a long-term digital healthcare value chain in Africa, all the way down to the last mile.”
The funding will be used to extend the startup’s operations throughout Uganda and into Kenya.